Hutch News
Continuing a legacy
Ahmed Diab, an inaugural winner of the Dr. Eddie Méndez Award, remembers his mentor
Stamping out bias with compassion and cartoons
Sikh Captain America visits the Hutch to talk storytelling, superheroes and strategies for fighting hate in life and at work
Personalized medicine for head and neck cancer
from the Mendez lab, Clinical Research Division, and Kemp lab, Human Biology Division
Functional genomics pinpoints unique tumor vulnerabilities
Technique pinpoints unique tumor vulnerabilities — even when they are not written in tumor DNA
AZD1775, a boost for platinum-based chemotherapy
From the Mendez Lab and Dr. Laura Chow, Clinical Research Division
Early phase clinical trial shows promise for advanced head and neck cancer
Nine out of 10 patients treated with the experimental therapy saw their tumors shrink
Data drives life sciences boom in Seattle
Hutch leaders, entrepreneurs stress importance of partnerships at Life Science Innovation Northwest conference
$7 million grants boost functional genomics team science
Dr. Chris Kemp’s 2 NCI awards will help support drug-target discovery and commercialization for personalized oncology
Remembering Dr. Eddie Méndez
Hutch friends and colleagues recall brilliant physician-scientist and ‘bright, shining star’
Good News: Dr. Eduardo Méndez receives $2.2M in NIH funding for targeted therapies for head and neck cancers
Celebrating faculty and staff achievements
Finding ways to deliver on the promise of precision oncology
‘Functional genomics’ method aims to marry three powerful techniques to speed personalized cancer treatments to patients
Forgotten patients: New guidelines help those with head-and-neck cancers
Stigma, isolation and medical complexity may keep patients from getting all the care they need; recommendations aim to change that
Drs. Colleen Delaney, Harlan Robins named 2016 Leaders in Health Care
Celebrating faculty and staff achievements
New hope for patients with hard-to-treat head and neck cancers
Treatment could shrink tumors before surgery and reduce chemotherapy’s damaging side effects; clinical trial to launch later this year
Team receives $4 million from national cancer institute to develop precision cancer treatments - Fred Hutchinson Cancer Research Center
Breakthrough research uses high-throughput screening to identify and target specific cancer genes in patients
Surviving head, neck cancers: 'where you're treated matters'
Dr. Eduardo Méndez, colleagues at Fred Hutchinson Cancer Research Center find high-volume hospitals, dedicated cancer centers produce higher survival rates in older head and neck cancer patients
Where you’re treated matters in terms of cancer survival - Fred Hutchinson Cancer Research Center
Older patients with head and neck cancers have higher survival rates when treated at high-volume hospitals and dedicated cancer centers, study found
ACS awards $720,000 for study of head and neck cancer metastasis
Eduardo Méndez of Fred Hutchinson Cancer Research Center’s Clinical Research Division leads four-year effort to identify gene targets, beneficial mutational status
Researchers identify genes that signal oral cancer spread
Discovery could lead to the development of a biomarker-based test in lieu of neck surgery